Широк набор от белязани и небелязани антитела, имуно-хистохимични китове, буфери и реактиви за диагностика на туморни образувания при цитологични и хистохимични изследвания.

CHEMICON International, Inc. has been in operation since 1981, supplying immunological reagents to the biomedical research community. In 1992, CHEMICON expanded into the area of diagnostic kits and reagents by supplying immunodiagnostic products for antigen detection of infectious disease. CHEMICON recently launched a line of molecular biology products designed for research and clinical applications. Our mission is to provide quality products and services to advance science within the research, diagnostic and the pharmaceutical communities.

CHEMICON develops, manufactures, markets, and distributes over 6,000 products spanning many scientific disciplines including Neuroscience, Adhesion, Apoptosis, Cell Signaling and Infectious Disease. In addition, CHEMICON has developed a diverse portfolio of proprietary technologies including a method for making fusion proteins (GST), Leukemia Inhibitory Factor (LIF), and Bioluminescence Proteins.

CHEMICON has experienced consistent growth over the past 20 years. The company currently employs over 200 professionals ranging from laboratory technicians to Ph.D. scientists and business personnel. The new corporate facility located in Temecula, California consists of 84,700 square feet and maintains the central operation including R&D, Manufacturing, Operations, Sales, Marketing, and Administration.

CHEMICON International, Inc. markets its products with a direct sales team in North America and through a network of distributors throughout the world. CHEMICON has expanded its physical operations and maintains state-of-the-art cGMP certified, TGA and ISO approved custom manufacturing facilities in the United States, Australia, and the United Kingdom.